In 2022, the production value of metabolic drugs amounted to around 1.4 trillion Japanese yen. The figure increased compared to around 1.16 trillion Japanese yen in 2019.
Production value of metabolic drugs in Japan from 2019 to 2022
(in trillion Japanese yen)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
MHLW (Japan). (March 19, 2024). Production value of metabolic drugs in Japan from 2019 to 2022 (in trillion Japanese yen) [Graph]. In Statista. Retrieved November 23, 2024, from https://www.statista.com/statistics/1463079/japan-production-value-of-metabolic-drugs/
MHLW (Japan). "Production value of metabolic drugs in Japan from 2019 to 2022 (in trillion Japanese yen)." Chart. March 19, 2024. Statista. Accessed November 23, 2024. https://www.statista.com/statistics/1463079/japan-production-value-of-metabolic-drugs/
MHLW (Japan). (2024). Production value of metabolic drugs in Japan from 2019 to 2022 (in trillion Japanese yen). Statista. Statista Inc.. Accessed: November 23, 2024. https://www.statista.com/statistics/1463079/japan-production-value-of-metabolic-drugs/
MHLW (Japan). "Production Value of Metabolic Drugs in Japan from 2019 to 2022 (in Trillion Japanese Yen)." Statista, Statista Inc., 19 Mar 2024, https://www.statista.com/statistics/1463079/japan-production-value-of-metabolic-drugs/
MHLW (Japan), Production value of metabolic drugs in Japan from 2019 to 2022 (in trillion Japanese yen) Statista, https://www.statista.com/statistics/1463079/japan-production-value-of-metabolic-drugs/ (last visited November 23, 2024)
Production value of metabolic drugs in Japan from 2019 to 2022 (in trillion Japanese yen) [Graph], MHLW (Japan), March 19, 2024. [Online]. Available: https://www.statista.com/statistics/1463079/japan-production-value-of-metabolic-drugs/